These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9548461)
1. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines. Inoue S; Kontani K; Tsujimoto N; Kanda Y; Hosoda N; Hoshino S; Hazeki O; Katada T J Immunol; 1997 Dec; 159(11):5226-32. PubMed ID: 9548461 [TBL] [Abstract][Full Text] [Related]
2. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. Kitanaka A; Suzuki T; Ito C; Nishigaki H; Coustan-Smith E; Tanaka T; Kubota Y; Campana D J Immunol; 1999 Feb; 162(4):1952-8. PubMed ID: 9973464 [TBL] [Abstract][Full Text] [Related]
3. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells. Konopleva M; Estrov Z; Zhao S; Andreeff M; Mehta K J Immunol; 1998 Nov; 161(9):4702-8. PubMed ID: 9794400 [TBL] [Abstract][Full Text] [Related]
4. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. Kitanaka A; Ito C; Coustan-Smith E; Campana D J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454 [TBL] [Abstract][Full Text] [Related]
5. Signal transduction via the CD38/NAD+ glycohydrolase. Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of chemotactic peptide-induced superoxide generation by CD38 ligation in human myeloid cell lines. Tsujimoto N; Kontani K; Inoue S; Hoshino S; Hazeki O; Malavasi F; Katada T J Biochem; 1997 May; 121(5):949-56. PubMed ID: 9192738 [TBL] [Abstract][Full Text] [Related]
7. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. Lund FE; Yu N; Kim KM; Reth M; Howard MC J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells. Kontani K; Kukimoto I; Nishina H; Hoshino S; Hazeki O; Kanaho Y; Katada T J Biol Chem; 1996 Jan; 271(3):1534-7. PubMed ID: 8576149 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45. Rankin BM; Yocum SA; Mittler RS; Kiener PA J Immunol; 1993 Jan; 150(2):605-16. PubMed ID: 8419492 [TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes. Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395 [TBL] [Abstract][Full Text] [Related]
11. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056 [TBL] [Abstract][Full Text] [Related]
12. Induction of CD38/NADase and its monoclonal antibody-induced tyrosine phosphorylation in human leukemia cell lines. Kontani K; Kukimonto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Katada T Biochem Biophys Res Commun; 1996 May; 222(2):466-71. PubMed ID: 8670228 [TBL] [Abstract][Full Text] [Related]
13. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma. Ellis JH; Barber KA; Tutt A; Hale C; Lewis AP; Glennie MJ; Stevenson GT; Crowe JS J Immunol; 1995 Jul; 155(2):925-37. PubMed ID: 7608568 [TBL] [Abstract][Full Text] [Related]
14. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785 [TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells. Yamashita Y; Miyake K; Kikuchi Y; Takatsu K; Noda S; Kosugi A; Kimoto M Immunology; 1995 Jun; 85(2):248-55. PubMed ID: 7642213 [TBL] [Abstract][Full Text] [Related]
16. Nuclear CD38 in retinoic acid-induced HL-60 cells. Yalcintepe L; Albeniz I; Adin-Cinar S; Tiryaki D; Bermek E; Graeff RM; Lee HC Exp Cell Res; 2005 Feb; 303(1):14-21. PubMed ID: 15572023 [TBL] [Abstract][Full Text] [Related]
17. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576 [TBL] [Abstract][Full Text] [Related]